SpyGlass Pharma, Inc. SGP

Set alert

Price alert · SGP

All alert types
33.64 USD +1.40 +4.34%

At close · Nov 2

33.64 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
33.54 × 2
Ask
33.96 × 2
31.60 Day range 33.96
17.06 52-week range 33.96
YTD
+27.42%
1 year
+27.42%
Open
32.71
Prev close
32.24
Mkt cap
1.13B
Vol
94.82K
Avg vol
102.06K
EPS
-2.51
P/E
0.00
Div yield
0.00%
More statistics
Low
31.60
High
33.96
Forward P/E
-11.95
Beta
0.00
Short ratio
9.43
Inst. own
94.68%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
27.23
200-d avg
24.36
1y target
44.00

5D chart

Chart tools
Interval

Signals (136)
NameTimeAgo
SMA: BearishNov 2, 10:10 AM21 hours ago
RSI: OverboughtNov 2, 9:40 AM21 hours ago
SMA: BullishOct 30, 3:45 PM3 days ago
SMA: BullishOct 30, 3:45 PM3 days ago
SMA: BearishOct 30, 3:40 PM3 days ago
SMA: BearishOct 30, 3:30 PM3 days ago
SMA: BullishOct 30, 3:05 PM3 days ago
SMA: BearishOct 30, 3:00 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
MACD: Buy SignalOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:50 PM3 days ago
MACD: Sell SignalOct 30, 2:50 PM3 days ago
SMA: BullishOct 30, 2:45 PM3 days ago
MACD: Buy SignalOct 30, 2:45 PM3 days ago
MACD: Sell SignalOct 30, 2:40 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BullishOct 30, 2:00 PM3 days ago

Newest 20 of 136.

Financial health

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -21.1×
FY 2025: -21.1×
FY 2025 5y median -21.1× FY 2025
P/S 0.0×
FY 2025: 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.5×
FY 2025: -8.5×
FY 2025 5y median -8.5× FY 2025
P/FCF -25.2×
FY 2025: -25.2×
FY 2025 5y median -25.2× FY 2025
EV/EBITDA -19.0×
FY 2025: -19.0×
FY 2025 5y median -19.0× FY 2025
EV/Sales 0.0×
FY 2025: 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -4.0%
FY 2025: -4.0%
FY 2025 5y median -4.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 40.3%
FY 2025: 40.3%
FY 2025 5y median 40.3% FY 2025
ROIC -38.6%
FY 2025: -38.6%
FY 2025 5y median -38.6% FY 2025
ROA -34.4%
FY 2025: -34.4%
FY 2025 5y median -34.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025: 0.0%
FY 2025 FY 2025

Financial Health

Current Ratio 12.7×
FY 2025: 12.7×
FY 2025 5y median 12.7× FY 2025
Quick Ratio 12.7×
FY 2025: 12.7×
FY 2025 5y median 12.7× FY 2025
Debt / Equity -0.0×
FY 2025: -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 2.4×
FY 2025: 2.4×
FY 2025 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2025: 0.0×
FY 2025 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31